SUPN : Analysis & Opinions

  1. Supernus Files Oxtellar XR Patent Infringement Lawsuit Again ...

    January 26, 2015
    Supernus Pharmaceuticals, Inc. (SUPN) filed a patent infringement lawsuit against TWi accusing the latter of infringement ...
  2. Supernus Downgraded as Lead Drugs Face Patent Challenges - Analyst ...

    January 20, 2015
    Zacks Investment Research downgraded Supernus Pharmaceuticals (SUPN) to a Zacks Rank #4 (Sell) on Jan 20.
  3. Actavis' Appeal Case for Namenda Gets Accelerated Hearing - ...

    January 7, 2015
    Actavis plc (ACT) confirmed that the U.S. Court of Appeals for the Second Circuit has granted the company's motion to expedite ...
  4. KaloBios Pharmaceuticals' KB001-A Fails Primary Endpoint - Analyst ...

    January 7, 2015
    KaloBios Pharmaceuticals, Inc. (KBIO) announced that one of its principal candidates, KB001-A, has failed to meet the primary ...
  5. New Ratings: FB, SUPN, SDR, TLYS, EVER

    May 29, 2012
    New York, May 29th (TradersHuddle.com) - These are the research analyst new ratings before the market open. Facebook (NASDAQ:FB) ...
Trading Center